Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long NVO ETF

8.95
-0.1550-1.70%
Volume:210.39K
Turnover:1.88M
Market Cap:37.46M
PE:- -
High:9.03
Open:8.91
Low:8.88
Close:9.10
52wk High:33.84
52wk Low:8.88
Shares:4.19M
Float Shares:4.19M
Volume Ratio:1.13
T/O Rate:5.02%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Novo Nordisk Says New Obesity Drug Outperformed Lilly's Zepbound in Phase 3 Trial

Dow Jones
·
Sep 21

Novo Nordisk A/S Stock (NVO) Moved Down by 7.86% on Sep 21: A Full Analysis

TradingKey
·
Sep 21

Novo Stock (NVO) Sinks Despite Beating Eli Lilly in New CagriSema Obesity Trial

TIPRANKS
·
Sep 21

Sector Update: Healthcare

MT Newswires Live
·
Sep 21

Update: Oil Price Decline Lifts US Equity Futures Pre-Bell

MT Newswires Live
·
Sep 21

Why Novo Stock is Dropping After Drugmaker Unveils Ambitious Growth Plan

Dow Jones
·
Sep 21

【US Pre-Market】US-China Talks Boost Markets, Bitcoin Rises to $85,000, Greenland Concept Stocks Surge, Oil Falls for Fourth Day

TradingKey
·
Sep 21

Novo Nordisk's Weight-Loss, Diabetes Drug Candidate Meets Primary Goals

MT Newswires Live
·
Sep 21

Goldman Sachs Sticks to Their Hold Rating for Novo Nordisk (0QIU)

TIPRANKS
·
Sep 21

Novo Says Its Next-Gen Obesity Drug Tops Lilly Rival in Late-Stage Study

Reuters
·
Sep 21

Why Is Novo Stock (NVO) Falling in Pre-Market Today, September 21?

TIPRANKS
·
Sep 21

Novo Nordisk Drops Over 7% Pre-Market as Wegovy Sales Miss Expectations

TradingKey
·
Sep 21

Market Chatter: Novo Nordisk Urged by Shareholders to Develop New Medicines, Pursue Acquisitions

MT Newswires Live
·
Sep 21

Novo Nordisk Aims for $23 Billion in 2035 Pipeline Sales

MT Newswires Live
·
Sep 21

Novo Nordisk Stock Tumbles as Ozempic Maker Sets Out 2030 Goals

Dow Jones
·
Sep 21

Wegovy Maker Novo Nordisk Targets Several New Blockbuster Drugs in Coming Years

Dow Jones
·
Sep 21

Novo Unveils Ambitious Pipeline Plans, Yet Shares Slide 6% as Investors Seek More

Trading Random
·
Sep 21

Eli Lilly, Novo sued over risk of sudden vision loss, WSJ reports

TIPRANKS
·
Sep 20

Health Advisory: Avoid Misusing Weight-Loss Medications, Prioritize Evaluation Before Treatment

Deep News
·
Sep 19

Novo Nordisk’s Once-Weekly Insulin Study Signals a New Phase for Diabetes Care

TIPRANKS
·
Sep 19